Keytruda Posts on Medivizor
Navigation Menu

Keytruda Posts on Medivizor

ASCO 2018: Chemotherapy Side Effects & Treating Metastatic Lung Cancer

ASCO 2018: Chemotherapy Side Effects & Treating Metastatic Lung Cancer

Posted by on Jun 4, 2018 in Blog, Colorectal cancer, Lung cancer | 0 comments

The American Society of Clinical Oncology (ASCO) meets at the beginning of June each year in Chicago. It is the world’s largest oncology organization where researchers from around the world present their research findings. Here are the results of two studies presented during the first couple of days of the conference. Chemotherapy Side Effects and...

Read More

If Not For Immunotherapy…

If Not For Immunotherapy…

Posted by on Oct 10, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 2 comments

“I’m barely 27 and if it were not for immunotherapy and cancer research, I would not have seen 25.”  So starts Stefanie Joho speech at a 2017 Congressional Hearing called “Progress in Immunotherapy: Delivering Hope and Clinical Benefit to Cancer Patients.” When Stefanie was 22, she was diagnosed with a very aggressive Stage II...

Read More

Quick Guide: Understanding the Importance of the FDA’s Keytruda Approval

Quick Guide:  Understanding the Importance of the FDA’s Keytruda Approval

Posted by on May 26, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Lung cancer, Melanoma, Prostate cancer | 0 comments

In July 2015, we published a post called Patients Included In Research: Studying Cancer by Mutation Not Organ.  In that post, we shared the goal that cancers would be treated not by the site of origin, but rather by their genetic features.  Achieving this goal is closer than you think! This week the FDA announced accelerated approval** of a...

Read More